Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer-Reference-Cited by-同舟云学术

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

Published:2018-11-09 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Liu Yunhua^ORCID,Xu Jiangsheng,Choi Hyun Ho,Han Cecil,Fang Yuanzhang,Li Yujing,Van der Jeught Kevin^ORCID,Xu Hanchen,Zhang Lu,Frieden Michael,Wang Lifei,Eyvani Haniyeh,Sun Yifan,Zhao Gang^ORCID,Zhang Yuntian,Liu Sheng,Wan Jun,Huang Cheng,Ji Guang^ORCID,Lu Xiongbin,He Xiaoming^ORCID,Zhang Xinna

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-07264-0.pdf

Reference63 articles.

1. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med 15, 907–913 (2009).

2. Prat, A. & Perou, C. M. Mammary development meets cancer genomics. Nat. Med 15, 842–844 (2009).

3. Seidman, A. D. et al. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. J. Clin. Oncol. 26, 1642–1649 (2008).

4. Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med 344, 783–792 (2001).

5. Vogel, C. L. et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20, 719–726 (2002).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of multiple microRNAs by microchip electrophoresis assisted by strand displacement amplification;Journal of Chromatography A;2024-08

2. Secondary Analysis of Human Bulk RNA-Seq Dataset Suggests Potential Mechanisms for Letrozole Resistance in Estrogen-Positive (ER+) Breast Cancer;Current Issues in Molecular Biology;2024-07-06

3. Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy;Scientific Reports;2024-03-19

4. AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer;Cell Death & Disease;2023-12-01

5. SEC61G assists EGFR -amplified glioblastoma to evade immune elimination;Proceedings of the National Academy of Sciences;2023-07-31